What is the stability of Zavicefta (ceftazidime/avibactam) and aztreonam after reconstitution?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Stability of Zavicefta/Aztreonam After Reconstitution

For aztreonam, use reconstituted solutions within 48 hours at room temperature (15°C-30°C) or within 7 days if refrigerated (2°C-8°C) at concentrations ≤2% w/v; for Zavicefta (ceftazidime-avibactam), the stability is significantly more limited and problematic for extended storage, particularly in elastomeric devices used for outpatient therapy.

Aztreonam Stability (FDA-Approved)

The FDA labeling provides clear, authoritative guidance for aztreonam stability 1:

Standard Concentrations (≤2% w/v):

  • Room temperature (15°C-30°C): 48 hours
  • Refrigerated (2°C-8°C): 7 days

Higher Concentrations (>2% w/v):

  • Use promptly after preparation for most diluents
  • Exception: Solutions prepared with Sterile Water for Injection or 0.9% Sodium Chloride maintain the same 48-hour/7-day stability as lower concentrations 1

Admixtures with Other Antibiotics:

When aztreonam is mixed with other agents in 0.9% sodium chloride or 5% dextrose 1:

  • With clindamycin, gentamicin, tobramycin, or cefazolin: Stable 48 hours at room temperature or 7 days refrigerated
  • With ampicillin in 0.9% sodium chloride: 24 hours at room temperature, 48 hours refrigerated
  • With ampicillin in 5% dextrose: Only 2 hours at room temperature, 8 hours refrigerated
  • Incompatible with: Nafcillin, cephradine, and metronidazole

Ceftazidime-Avibactam (Zavicefta) Stability

The stability picture for ceftazidime-avibactam is considerably more complex and restrictive:

Critical Limitation - Pyridine Formation:

The major stability concern is pyridine accumulation, a degradation product that exceeds European Pharmacopeia limits even during refrigerated storage 2. This is a critical safety issue that limits practical use in extended infusion devices.

Elastomeric Device Studies:

Recent high-quality research reveals significant stability challenges 3, 2:

  • After 14 days refrigerated storage (2°C-8°C) followed by 24 hours at 32°C:

    • Ceftazidime remaining: 75.5%-85.4% (depending on concentration and device)
    • Avibactam remaining: 83.2%-93.1%
    • Pyridine levels: Exceeded acceptable limits after refrigerated storage alone 2
  • For OPAT use: Degradation remains <10% for at least 12 hours of running phase only if stored refrigerated for ≤72 hours prior to use 3

Practical Recommendation for Combined Therapy:

When using ceftazidime-avibactam with aztreonam (for metallo-β-lactamase producers):

  • Y-site compatibility is confirmed at clinically relevant concentrations 4:

    • Ceftazidime-avibactam: 8,25, and 50 mg/mL
    • Aztreonam: 10 and 20 mg/mL
    • Compatible for at least 12 hours after mixing
  • Administer as simultaneous infusions rather than pre-mixed solutions to avoid extended storage stability issues 5

Clinical Algorithm for Storage and Use

For Aztreonam Alone:

  1. Reconstitute to ≤2% w/v concentration
  2. Store refrigerated (2°C-8°C) for up to 7 days OR
  3. Keep at room temperature for up to 48 hours
  4. Inspect for color changes (slight pink tint acceptable) or particulates before use 1

For Ceftazidime-Avibactam:

  1. Prepare fresh whenever possible
  2. If advance preparation needed: refrigerate for maximum 72 hours before use 3
  3. Do not use elastomeric devices for >12-hour infusions due to pyridine accumulation 2
  4. Administer within 12 hours of reaching room/body temperature

For Combined Ceftazidime-Avibactam + Aztreonam:

  1. Prepare each agent separately
  2. Administer via Y-site simultaneously 4
  3. Complete infusion within 12 hours of mixing
  4. Use continuous or extended infusions (q6h preferred over q8h for optimal PK/PD) 5

Critical Pitfalls to Avoid

  • Do not assume ceftazidime-avibactam has the same stability as aztreonam - it degrades much faster and produces toxic pyridine 2
  • Do not pre-mix ceftazidime-avibactam and aztreonam for extended storage - administer simultaneously via Y-site instead 4
  • Do not use 14-day refrigerated storage protocols developed for other antibiotics with ceftazidime-avibactam 3, 2
  • Do not use ceftazidime-avibactam in 24-hour elastomeric pumps - pyridine limits are exceeded 2

The older guideline data showing ceftazidime stability of 21 days refrigerated 6 predates avibactam combination products and should not be extrapolated to Zavicefta.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.